Global Solutions Team
Our leadership team has the extensive specialty and rare disease, market access, marketing and financial expertise needed to provide a consultative approach for branded specialty products to be brought to market successfully.
Meet Our Global Leaders
Dea Belazi
Chief Executive Officer
Dea brings to AscellaHealth over two decades of impressive leadership and C-level management experience within the healthcare industry and is responsible for the development of PerformRx, a PBM owned by Keystone First Health Plan and Future Scripts, an Independence Blue Cross company sold to Catamaran. Dea was selected as a 2021 Most Admired CEO Honoree by the Philadelphia Business Journal and a 2022 and 2023 Titan 100 Honoree.
Bill Oldham
Chairman & President
Bill is Founder of Oldham Global, a focused investment company building solutions in FinTech, health IT, and health services. Most impressively under Bill’s leadership, AscellaHealth has experienced a 1556% revenue growth over the last 4 years attributed to both organic growth and acquisitions. Bill was selected as a 2022 CFO of the Year Honoree by the Philadelphia Business Journal and a 2023 Titan 100 Honoree.
Mario Patone
Chief Financial Officer
John Campolongo
Chief Operating Officer
Andy Szczotka
Chief Pharmacy Officer
Lisa Crowley
Chief of Staff
Craig Caceci
Executive Vice President / Managing Director, EU/UK
Donovan Quill
Executive Vice President, Growth & Strategy
Denise Cubbin
Senior Vice President, Operations
Bob Gilkin
Senior Vice President, Trade & Specialty Strategy
Dea Belazi at the 2024 Healthkey Summit
For more information about AscellaHealth
Awards and Accolades
AscellaHealth is proud to be recognized as a leading global specialty pharmacy and healthcare services organization. We have won multiple awards both within and outside of the healthcare industry.
